Medical Marijuana and Mental Health. Pros and Cons

[HereSince1628]

3. FYI Results of a Survey of Psychiatrists on MJ are published in Psychiatric Times

Psychiatric Times requires you to open an account... but

News | July 11, 2013 | Substance Use Disorder, PTSD, Psychopharmacology
By Susan Kweskin

The Dope on Medical Cannabis: Results of a Survey of Psychiatrists


If our survey on medical cannabis is any indication, psychiatrists are widely—and deeply—divided on whether and how marijuana should be used in clinical practice. Feelings are running, well . . . high, about whether, when, or in what circumstances this drug might be prescribed for patients with psychiatric disorders.


We invited psychiatrists to complete a survey about medicinal marijuana and didn’t expect nearly 2200 people to complete that survey in a just a few days. We heard from 1138 psychiatrists, 930 of whom practice in the US. We also heard from 109 psychologists, 163 nurse practitioners, and 22 physician assistants. About 30% of the respondents were 51 - 60 years old; 20% were 41 - 50; and 22% were 61 - 71. The minority (40%) live in a state where medical cannabis is legal.

- See more at: http://www.psychiatrictimes.com/substance-use-disorder/dope-medical-cannabis-results-survey-psychiatrists/page/0/1?GUID=CBA4F64C-561D-4B53-A576-506E8F3435F7&rememberme=1&ts=18072013#sthash.pisvSm6B.dpuf